Singapore markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
44.08-0.49 (-1.10%)
At close: 04:03PM EDT
44.10 +0.02 (+0.05%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 247.39B
Enterprise value 254.37B
Trailing P/E 8.58
Forward P/E 9.23
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.50
Price/book (mrq)2.84
Enterprise value/revenue 2.51
Enterprise value/EBITDA 6.61

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 31.17%
S&P500 52-week change 3-16.88%
52-week high 361.71
52-week low 340.94
50-day moving average 348.37
200-day moving average 351.22

Share statistics

Avg vol (3-month) 317.71M
Avg vol (10-day) 318.04M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.05%
% held by institutions 170.21%
Shares short (30 Aug 2022) 462.2M
Short ratio (30 Aug 2022) 43.47
Short % of float (30 Aug 2022) 41.11%
Short % of shares outstanding (30 Aug 2022) 41.11%
Shares short (prior month 28 Jul 2022) 459.9M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 43.63%
Trailing annual dividend rate 31.58
Trailing annual dividend yield 33.54%
5-year average dividend yield 43.60
Payout ratio 430.74%
Dividend date 305 Sept 2022
Ex-dividend date 402 Nov 2022
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)02 Jul 2022

Profitability

Profit margin 28.94%
Operating margin (ttm)38.05%

Management effectiveness

Return on assets (ttm)13.19%
Return on equity (ttm)37.40%

Income statement

Revenue (ttm)101.28B
Revenue per share (ttm)18.06
Quarterly revenue growth (yoy)46.80%
Gross profit (ttm)50.63B
EBITDA 43.52B
Net income avi to common (ttm)29.48B
Diluted EPS (ttm)5.14
Quarterly earnings growth (yoy)78.10%

Balance sheet

Total cash (mrq)33.31B
Total cash per share (mrq)5.93
Total debt (mrq)40.49B
Total debt/equity (mrq)46.29
Current ratio (mrq)1.42
Book value per share (mrq)15.59

Cash flow statement

Operating cash flow (ttm)31.45B
Levered free cash flow (ttm)29.06B